PharmaResearch Co., Ltd. Q3 revenue KRW 171.5 billion, operating profit KRW 62.6 billion, up 1.2% year on year
PAI summary · Not investment advice
Pharma Research sold KRW 171.5 billion in the third quarter and earned KRW 62.6 billion from its main business, up 1.2% from a year earlier.
Operating profit · 3 months
KRW 62.6 billion
Key facts
- Revenue (3 months)
- KRW 171.5 billion
- Net income (3 months)
- KRW 30.2 billion
- Period
- Q3 (cumulative 2026.01.01 ~ 2026.09.30)
- Revenue (prior-year 3 months)
- KRW 135.4 billion
- Revenue (year to date)
- KRW 496.3 billion
- Operating profit (prior-year 3 months)
- KRW 61.9 billion
- Operating profit (year to date)
- KRW 186.4 billion
- Net income (prior-year 3 months)
- KRW 50.9 billion
- Net income (year to date)
- KRW 135.2 billion
Commentary
AI commentary · Not investment advice
What happened
Pharma Research reported its consolidated results for the third quarter of 2026. Sales for the latest 3 months were KRW 171.5 billion. That is up 26.7% from KRW 135.4 billion in the same 3 months a year earlier.
In the company's terms
Operating profit (profit from the core business) for the 3 months was KRW 62.6 billion. That is up 1.2% from KRW 61.9 billion a year earlier. Net income (the final profit after taxes and other costs) for the 3 months was KRW 30.2 billion. That is down 40.5% from KRW 50.9 billion a year earlier.
What changes for shareholders
For the year to date (January 1 to September 30), sales were KRW 496.3 billion. Operating profit was KRW 186.4 billion. Net income was KRW 135.2 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist